ArticleFrontiers in oncology2023

FGFR inhibitors combined with nab-paclitaxel - A promising strategy to treat non-small cell lung cancer and overcome resistance.

Feng Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.